Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?

Ann Transl Med. 2020 Dec;8(24):1695. doi: 10.21037/atm-2020-130.

Authors

Kit Shing¹, Gerry Kwok¹, Joanne Chiu¹, Tan To Cheung², Thomas Yau¹

Affiliations

¹ Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
² Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.

No abstract available

Publication types

Editorial
Comment